Tag: pharmaceutical news

U.S. regulators have greenlit Eli Lilly’s tirzepatide, a drug formulated for the treatment of adult patients diagnosed with type 2 diabetes. Clinical studies indicate that tirzepatide, in conjunction with diet and physical activity, is more effective than other medications in normalizing blood glucose levels. Tirzepatide, designed for subcutaneous administration once per week, also supports obese…